Výsledky vyhledávání

A Novel Combination of Decitabine and Etoposide Greatly Improves the Survival of TP53 Mutation AML/MDS Patients by Targeting Notch1 Signaling Pathway

Autor: Shunrong Sun, Yanhui Xie, Hehe Sheng, Yingwei Hu, Jiexian Ma, Zhaolin Zhou, Min Wu, Mixue Xie, Jingsheng Hua, Ruyu Yang, Xiaohua Wang, Xiaoqin Wang, Xiujin Ye

Publikováno v: SSRN Electronic Journal.

There is still a lack of effective treatments for elderly AML/MDS patients, especially those with TP53 mutation. We conducted a prospective, multicenter clinical trial to evaluate decitabine and etoposide based regimen in elderly AML/MDS patients and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b4673fe4b8b7aebc76e87e99074d734e
https://doi.org/10.2139/ssrn.3707242

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání